What Is BioKier?
BioKier is an early-stage medical food and pharmaceutical company developing new proprietary products for diabetes and related disorders. BioKier has identified a therapeutic opportunity and is developing a novel oral product for management and treatment for type 2 diabetes and related comorbidities. This product will potentially also have effects in metabolic syndrome and obesity.
BioKier, Inc. has created a network of partnerships with experts in pharmaceutical development, medical treatment, business strategy, law, and laboratory services. This allows BioKier to utilize specialized guidance and advice at every step of the development process.
Recently David Menzies from Carolina Tech News interviewed Dr George Szewczyk, CEO of BioKier, Inc. Read More